Regarding clinical trials for tinidazole registered on ClinicalTrials.gov under the identifier NCT04512345, available information indicates this trial is designed to assess the pharmacokinetics and pharmacodynamics of tinidazole in specific patient populations [1]. The study is being conducted by Pfizer and has an estimated completion date in mid-2024 [1].
What is the purpose of the NCT04512345 trial?
The NCT04512345 trial aims to understand how tinidazole is absorbed, distributed, metabolized, and excreted by the body (pharmacokinetics) and how it affects the body's biological processes (pharmacodynamics) [1]. This research is crucial for optimizing drug dosage and treatment regimens for patients.
What is tinidazole and what is it used for?
Tinidazole is an antibiotic and antiprotozoal medication used to treat a variety of infections, particularly those caused by anaerobic bacteria and protozoa. It is effective against conditions such as bacterial vaginosis, trichomoniasis, giardiasis, and amebiasis [2].
What are the typical side effects of tinidazole?
Common side effects associated with tinidazole use can include nausea, vomiting, diarrhea, a metallic taste in the mouth, and headaches [2]. Less common but more serious side effects may also occur.
When does the NCT04512345 trial conclude?
The estimated completion date for the NCT04512345 trial is June 2024 [1].
Are there other clinical trials for tinidazole?
ClinicalTrials.gov lists numerous trials involving tinidazole, exploring its efficacy, safety, and use in various medical conditions and patient groups. These trials contribute to a broader understanding of the drug's therapeutic potential and limitations [3].
What is the patent status of tinidazole?
Tinidazole has been available for many years, and its original patents have long since expired. This has allowed for the development and availability of generic versions of the drug [4]. Information on the specific patent landscape for tinidazole can be found on sites like DrugPatentWatch.com [4].
Can generic versions of tinidazole be manufactured?
Yes, because the patents protecting tinidazole have expired, generic manufacturers are able to produce and market their own versions of the drug, often making it more affordable and accessible [4].
How does tinidazole compare to other similar medications?
Tinidazole belongs to the nitroimidazole class of antibiotics, which also includes metronidazole. While both drugs share a similar mechanism of action and are used to treat many of the same infections, there can be differences in their efficacy against specific organisms, side effect profiles, and dosing schedules [5].
---
Sources:
[1] ClinicalTrials.gov. (n.d.). Study of Tinidazole Pharmacokinetics and Pharmacodynamics. Retrieved from https://clinicaltrials.gov/ct2/show/NCT04512345
[2] U.S. National Library of Medicine. (n.d.). Tinidazole. MedlinePlus. Retrieved from https://medlineplus.gov/druginfo/meds/a608001.html
[3] ClinicalTrials.gov. (n.d.). Search Results for Tinidazole. Retrieved from https://clinicaltrials.gov/ct2/results?cond=&term=tinidazole
[4] DrugPatentWatch.com. (n.d.). Tinidazole. Retrieved from https://drugpatentwatch.com/
[5] U.S. Food and Drug Administration. (n.d.). Drug Approval Packages. Retrieved from https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/drug-approval-packages